Evolution from Gene Discovery to Drug Development
TL;DR Summary
Howard Chang, a renowned genomic researcher and dermatologist, transitioned from academia and biotech startups to become Amgen's new CSO, focusing on genetic target discovery, extrachromosomal DNA, and technology development to advance drug discovery.
Topics:science#biotech#drug-development#extrachromosomal-dna#gene-discovery#howard-chang#science-and-technology
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 1 min read
Condensed
76%
136 → 33 words
Want the full story? Read the original article
Read on Nature